Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Comparison of micafungin and fosfluconazole as prophylaxis for invasive fungal infection during neutropenia in children undergoing chemotherapy and hematopoietic stem cell transplantation].
Sawada A, Sakata N, Higuchi B, Takeshita Y, Ishihara T, Sakata A, Kouroki M, Kondo O, Koyama M, Hirano S, Yasui M, Inoue M, Yoshioka A, Kawa K. Sawada A, et al. Among authors: kondo o. Rinsho Ketsueki. 2009 Dec;50(12):1692-9. Rinsho Ketsueki. 2009. PMID: 20068276 Clinical Trial. Japanese.
Feasibility of HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for advanced pediatric malignancies.
Sawada A, Shimizu M, Isaka K, Higuchi K, Mayumi A, Yoshimoto Y, Kikuchi H, Kondo O, Koyama-Sato M, Yasui M, Kawa K, Inoue M. Sawada A, et al. Among authors: kondo o. Pediatr Hematol Oncol. 2014 Nov;31(8):754-64. doi: 10.3109/08880018.2014.961214. Epub 2014 Oct 17. Pediatr Hematol Oncol. 2014. PMID: 25325678 Clinical Trial.
HLA-haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioning with very low-dose antithymocyte globulin for relapsed/refractory acute leukemia in pediatric patients: a single-institution retrospective analysis.
Higuchi K, Sawada A, Kondo O, Okada Y, Tsujimoto H, Ioi A, Mayumi A, Shimizu M, Sato M, Goto K, Inoue S, Yasui M, Inoue M. Higuchi K, et al. Among authors: kondo o. Int J Hematol. 2022 Mar;115(3):406-413. doi: 10.1007/s12185-021-03270-z. Epub 2022 Jan 14. Int J Hematol. 2022. PMID: 35028882
Umbilical cord blood as an alternative source of reduced-intensity hematopoietic stem cell transplantation for chronic Epstein-Barr virus-associated T or natural killer cell lymphoproliferative diseases.
Sawada A, Inoue M, Koyama-Sato M, Kondo O, Yamada K, Shimizu M, Isaka K, Kimoto T, Kikuchi H, Tokimasa S, Yasui M, Kawa K. Sawada A, et al. Among authors: kondo o. Biol Blood Marrow Transplant. 2014 Feb;20(2):214-21. doi: 10.1016/j.bbmt.2013.10.026. Epub 2013 Nov 2. Biol Blood Marrow Transplant. 2014. PMID: 24188918 Free article.
53 results